NanoApps Medical, Inc. was incorporated in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds. The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Frank Boehm (NanoApps Medical, CEO) is now compiling a book that will articulate this grand vision. Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.